Key result
Heart failure patients exhibit progressively higher variability over time in IL-6 and TNF-alpha than receptors.
Why the study?
Despite increasing interest in cytokines as mediators of heart failure progression and targets for clinical studies, the extent of natural variability in circulating cytokines and cytokine receptors remained largely unknown.
Does heart failure increase the natural temporal variability of circulating cytokine and cytokine receptor levels compared to healthy controls?
Case-Control (n=20)
Does heart failure increase the natural temporal variability of circulating cytokine and cytokine receptor levels compared to healthy controls?
Because natural variability in circulating IL-6 and TNF-alpha increases over time in heart failure whereas soluble receptor levels remain stable, clinical trials using cytokines as endpoints must adjust sample sizes based on the specific biomarker and assay timeframe.
Answers are grounded in this paper and cite their sources.
May require larger samples in cytokine-focused heart failure trials due to rising variability; leaves open whether receptors offer more reliable endpoints.
Objectives The purpose of this study was to examine the variability in cytokines and cytokine receptors in patients with heart failure in comparison with a group of healthy control subjects who were free of cardiovascular disease. Background Despite increasing interest in cytokines as mediators of disease progression in heart failure and the recent interest in suppressing cytokines in clinical studies, the extent of variability in cytokines and cytokine receptors is largely unknown. This information is important for interpreting the results of studies in which changes in cytokine levels are measured in response to a specific form of therapy. Methods Circulating levels of tumor necrosis factor-alpha (TNF-alpha), and soluble TNF receptors (types 1 and 2), as well as interleukin (IL)-6 and IL-6 receptor were measured on a daily, weekly and monthly basis in heart failure patients (New York Heart Association class IIIa and IIIb; n = 10) and healthy volunteer subjects (n = 10). Measurements of cytokines and cytokine receptors were performed on plasma samples by enzyme-linked immunoassay. The daily, weekly and monthly degree of variability in cytokine and cytokine receptor levels was assessed by determining the coefficient of variation each point in time. Results The coefficient of variation for TNF-alpha and IL-6 levels increased over time in patients with heart failure; moreover, the coefficient of variation in heart failure subjects was significantly greater for IL-6 than for TNF-alpha. The coefficient of variation in cytokine receptor levels was minimal, and did not differ significantly between heart failure and control subjects. Conclusions In patients with heart failure the degree of natural variability in circulating cytokine levels increases with time, and is greater for IL-6 than for TNF-alpha. Accordingly, the results of the present study suggest that the sample size needed to show a statistically significant change in the circulating level of a given cytokine will vary depending on the specific cytokine that is being measured, as well as the time period over which that cytokine is being assayed.
No takes yet. Share an insight, caveat, or question.
Dibbs et al. (1999) conducted a case-control in Heart failure (n=20). Heart failure (NYHA class IIIa and IIIb) vs. Healthy volunteer subjects free of cardiovascular disease was evaluated on Coefficient of variation in circulating levels of cytokines (TNF-alpha, IL-6) and soluble cytokine receptors (sTNFR1, sTNFR2, IL-6R). Heart failure patients (n=10) exhibited increasing variability over time in TNF-alpha and IL-6 levels (IL-6 > TNF-alpha), whereas receptor variability remained minimal and similar to healthy controls (n=10).
Synapse has enriched 10 related papers. Consider them for comparative context: